论文部分内容阅读
成功地诱发排卵,是大多数妇科内分泌疾病治疗的关键。发展简便而有效的诱发排卵疗法是妇科医生及内分泌医生长期渴望解决和努力探求的课题。近20多年来,随着神经内分泌学研究的不断深入,出现了克罗米芬、人绝经期促性腺激素(hMG)、人绒毛膜促性腺激素(hCG)、溴隐亭及黄体生成素释放激素(LHRH)等一大批令人嘱目的诱发排卵剂。本文就这些药物的概况及近年临床上采用这些药物诱发排卵的结果作一综合分析。
Successful ovulation induction is the key to the treatment of most gynecological endocrine diseases. The development of simple and effective induction of ovulation therapy is a long-term desire of gynecologists and endocrinologists to solve and strive to explore the issue. In recent 20 years, with the continuous deepening of neuroendocrine research, clomiphene citrate, human menopausal gonadotrophin (hMG), human chorionic gonadotropin (hCG), bromocriptine and luteinizing hormone releasing hormone LHRH) and a large number of other people’s purpose to induce ovulation agents. In this paper, the general situation of these drugs and clinical use of these drugs in recent years, ovulation induction results for a comprehensive analysis.